Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of 3d culture medium of brain glioma organoid and its application

A technology of glioma and organoids, which is applied in the field of biomedicine, can solve the problems of colon, stomach, prostate and pancreas and other tissues that have been successfully constructed in vitro in organ culture, so as to avoid hypoxic damage, accelerate proliferation, The effect of promoting cluster growth

Active Publication Date: 2021-06-25
ACCURATE INT BIOTECHNOLOGY (GUANGZHOU) CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, although organoids from tissues such as colon, stomach, prostate, and pancreas have been successfully constructed in vitro using organoid culture, there are few reports on the use of surgically resected glioma tissue for organoid culture in glioma

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of 3d culture medium of brain glioma organoid and its application
  • A kind of 3d culture medium of brain glioma organoid and its application
  • A kind of 3d culture medium of brain glioma organoid and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] This embodiment provides a glioma organoid medium, including Neurocult NS-A basal medium and specific additive factors; the specific additive factors include components at the following final concentrations: B27 additive, 2%; Thiazovivin L-Glutamine, 0.1%; HGF, 25ng / ml; Insulin, 0.05%; FGF-2, 30ng / ml; dorsomorphin, 2.5μM; SB-431542, 25μM; EGF, 250ng / ml; BSA 5%; HEPES, 20mM; Heparin, 0.05%; human NLGN3, 100nM; double antibody, 1%; the aforementioned percentage concentration represents the mass concentration. The preparation method of the culture medium is as follows: according to the above-mentioned composition and ingredients of the culture medium, specific additive factors are added to the base culture medium and mixed evenly.

Embodiment 2

[0049] This embodiment provides a glioma organoid medium, including Neurocult NS-A basal medium and specific additive factors; the specific additive factors include components at the following final concentrations: B27 additive, 1%; Thiazovivin L-Glutamine, 0.05%; HGF, 50ng / ml; Insulin, 0.06%; FGF-2, 10ng / ml; dorsomorphin, 3μM; SB-431542, 20μM; EGF, 500ng / ml; HEPES, 30mM; 2%; Heparin, 0.01%; human NLGN3, 200nM; double antibody, 0.5%; the aforementioned percentage concentration represents the mass concentration. The preparation method of this medium is the same as that in Example 1.

Embodiment 3

[0051] This embodiment provides a glioma organoid medium, including Neurocult NS-A basal medium and specific additive factors; the specific additive factors include components at the following final concentrations: B27 additive, 5%; Thiazovivin , 1μM; L-Glutamine, 0.2%; HGF, 10ng / ml; Insulin, 0.03%; FGF-2, 50ng / ml; dorsomorphin, 2μM; SB-431542, 30μM; 9%; Heparin, 0.1%; human NLGN3, 50nM; double antibody, 5%; the aforementioned percentage concentration represents the mass concentration. The preparation method of this medium is the same as that in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a 3D culture medium for glioma organoids and its application. The culture medium includes basal medium and specific additive factors; the specific additive factors include the following final concentration components: B27 additive, 1 L-Glutamine, 0.05-0.2%; HGF, 10-50ng / ml; Insulin, 0.03-0.06%; FGF-2, 10-50ng / ml; dorsomorphin, 2-3μM; SB‑431542, 20‑30μM; EGF, 100‑500ng / ml; HEPES, 10‑30mM; BSA, 1~10%; Heparin, 0.01‑0.1%; Human NLGN3, 50‑200nM; %; the aforementioned percentage concentration represents the mass concentration. By adopting the culture medium of the present invention to cultivate glioma organoids, the glioma tissue cells can better exhibit their inherent activity characteristics during the culture process, and achieve comprehensive characteristics highly similar to living brain tissues.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and in particular relates to a 3D medium for glioma organoids and an application thereof. Background technique [0002] Glioma is a common malignant tumor of the central nervous system, accounting for about 40%-50% of intracranial tumors, mostly in the form of infiltrative growth, with unclear boundaries with the surrounding brain tissue, and difficult to be completely removed by surgery. It is easy to relapse after surgery; generally speaking, the higher the grade of the tumor, the higher its malignancy, and the faster the recurrence after surgery. At present, the treatment of glioma is mainly based on surgical resection combined with postoperative radiotherapy and chemotherapy, but the prognosis is poor. In recent years, no breakthrough has been made in the treatment of glioma. [0003] However, currently, there are only a handful of in vitro glioma models used in drug development and bas...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/09C12N5/079
CPCC12N5/0622C12N5/0693C12N2501/11C12N2501/115C12N2501/12C12N2501/13C12N2501/15C12N2501/33C12N2501/405C12N2501/73C12N2513/00
Inventor 陈泽新于言徐丛黄敏
Owner ACCURATE INT BIOTECHNOLOGY (GUANGZHOU) CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com